Glipizide

Dr. McPhee: This is not quite right for Mr. Green. Glipizide is a sulfonylurea that stimulates insulin secretion from the pancreas and thus can be used in type 2 diabetes in cases where first line drugs are not indicated or unavailable. However, it increases the risk of hypoglycaemia and tends to cause weight gain, which are not ideal for a patient who is overweight and has a history of hypertension. Sulfonylureas do not provide the same cardiovascular protection as other drugs, which is a major goal of diabetes management. Think carefully about the broader health context for Mr. Green and try again!

  • Ask rapid questions using medical jargon (ischemia, necrotic tissue, perfusion). [undo]
  • Ignore the wound complaint and focus solely on blood glucose. [undo]
  • Give an immediate diagnosis without exploring the patient’s narrative. [undo]
  • Verify patient identity and obtain e-consent before starting. [undo]
  • Ακολουθώ τις συμβουλές του γιατρού, διότι η κατάστασή μου μπορεί να αποβεί μοιραία αν αφεθεί αναξέλεγτη. [undo]
  • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication [undo]
  • Privacy risk [undo]
  • Allow the family member to stay on screen without clarifying their role [undo]
  • BrainHQ Συναισθηματικός παράγοντας [undo]
  • Pioglitazone [undo]
  • Αποφασίσαμε να κάνουμε ένα φιλανθρωπικό μπαζάρ. [undo]
  • Glipizide [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21089
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway